Recent Press Releases

Johnson & Johnson to Webcast Annual Meeting of Shareholders

NEW BRUNSWICK, N.J., March 27, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will webcast its A

Orexigen's Mysimba™ Approved in Europe for the Treatment of Obesity

SAN DIEGO, March 26, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the European Commission has granted marketing authorization for Mysimba™ (naltrexone...

Novo Nordisk A/S : Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba® and Ryzodeg® in the US

Bagsværd, Denmark, 26 March 2015 - Novo Nordisk today announced that the company has decided to submit the prespecified interim analysis of DEVOTE as part of a Class II Resubmission of the New...

Genentech Announces Plans To Expand Hillsboro Facility

Investment To Bring Up to 100 New Jobs to the State South San Francisco, Calif. -- March 26, 2015 -- Genentech, a member of the Roche Group, has announced plans to invest more than $125 million for...

Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against Cancer

THOUSAND OAKS, Calif., March 26, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that breast cancer

Sagent Pharmaceuticals Announces Leadership Changes

--Jeffrey Yordon Retires as Chairman and CEO; Board Member, Frank Kung, Ph.D. Appointed Chairman-- --Board Launches Search for Permanent CEO--...

GSK receives approval for Encruse® Ellipta® (umeclidinium) in Japan for the treatment of COPD

- Two further GSK products, Duac® Combination Gel and Synflorix™, also gain approval in Japan GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the Japanese Ministry of...

UCB takes "Customer Innovation" and "Lifetime Value Achievement" top honours for staff commitment to improving patient experience

Two of UCB's biggest patient innovators were yesterday announced as winners at the eyeforpharma Barcelona Awards for their long-term commitment to improve patient experience. Both Christi Marsh,...

Janssen Healthcare Innovation's Care4Today scores a double win at the eyeforpharma Barcelona Awards 2015

Not one, but two initiatives from Janssen Healthcare Innovation have been separately voted 'Most Valuable' at the eyeforpharma Barcelona Awards. This is the first time a single company has...

Sanofi Pasteur wins "Most Impactful Emerging or Global Initiative" for commitment to fighting Dengue Fever

Sanofi Pasteur's global awareness programme for Dengue Fever, 'Break Dengue', was yesterday announced the winner of the 'Most Impactful Emerging or Global Initiative' category at...

Sun Pharma announces closure of merger deal with Ranbaxy

Sun Pharma announces closure of merger deal with Ranbaxy Beginning today, integration to focus on enhancing productivity Value creation initiatives to deliver US$ 250 mn synergies in Year 3...

Novo Nordisk A/S: Saxenda® approved in Europe for the treatment of obesity

Bagsværd, Denmark, 23 March 2015 - Novo Nordisk today announced that the European Commission has granted marketing authorisation for Saxenda® (liraglutide 3 mg) for the treatment of...

First-in-class type 2 diabetes treatment Glyxambi® (empagliflozin/linagliptin) tablets for adults now available in U.S. pharmacies

New dual inhibitor SGLT2/DPP-4 combination therapy offers improved glycemic control as an adjunct to diet and exercise New GLYXAMBI savings program offered for eligible patients RIDGEFIELD, Conn.,...

Merck's Pivotal KEYNOTE-006 Study in First-Line Treatment for Advanced Melanoma Met Co-Primary Endpoints and Will be Stopped Early

KENILWORTH, N.J.--Merck ($MRK), known as MSD outside the United States and Canada, today announced that the randomized, pivotal Phase 3 study (KEYNOTE-006) investigating KEYTRUDA®...

When school is out, science is in! GSK Science in the Summer™ goes national

- Kids use chemistry to turn pennies golden in STEM experiments

PHILADELPHIA, March 23, 2015 /PRNews

Amgen To Webcast Investor Call At the 73rd Annual Meeting of the American Academy of Dermatology

THOUSAND OAKS, Calif., March 23, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for t

First-in-class type 2 diabetes treatment Glyxambi® (empagliflozin/linagliptin) tablets for adults now available in U.S. pharmacies

New dual inhibitor SGLT2/DPP-4 combination therapy offers improved glycemic control as an adjunct to diet and exercise

RIDGEFIELD, Conn.<

Serious and Life-Threatening Cases of Symptomatic Bradycardia as well as One Case of Fatal Cardiac Arrest Reported with Coadministration of amiodarone with either Harvoni® or with Sovaldi® in combination with another direct acting antiviral.

On March 20, 2015, FDA approved changes to the Harvoni (ledipasvir/sofosbuvir fixed dose combination) and Sovaldi (sofosbuvir) labels to update the WARNINGS AND PRECAUTIONS, ADVERSE REACTIONS, and...

EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals

HEMEL HEMPSTEAD, England, March 23, 2015 /PRNewswire via COMTEX/ -- HEMEL HEMPSTEAD, England, March 23, 2015 /PRNewswire/ -- EUSA Pharma (EUSA), a newly-established profitable specialty...

Biogen Idec Becomes Biogen

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB). The company has introduced a new corporate identity and logo that reflect both its evolution...